BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020;6:18. [PMID: 32165620 DOI: 10.1038/s41572-020-0149-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 56.0] [Reference Citation Analysis]
Number Citing Articles
1 Vellaichamy G, Dimitrion P, Zhou L, Ozog D, Lim HW, Liao W, Hamzavi IH, Mi QS. Insights from γ-Secretase: Functional Genetics of Hidradenitis Suppurativa. J Invest Dermatol 2021;141:1888-96. [PMID: 33836848 DOI: 10.1016/j.jid.2021.01.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zouboulis CC, Frew JW, Giamarellos-Bourboulis EJ, Jemec GBE, Del Marmol V, Marzano AV, Nikolakis G, Sayed CJ, Tzellos T, Wolk K, Prens EP. Target molecules for future hidradenitis suppurativa treatment. Exp Dermatol 2021;30 Suppl 1:8-17. [PMID: 34085329 DOI: 10.1111/exd.14338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
3 Navrazhina K, Garcet S, Zheng X, Hur HB, Frew JW, Krueger JG. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression. J Allergy Clin Immunol 2021:S0091-6749(21)00832-0. [PMID: 34081946 DOI: 10.1016/j.jaci.2021.05.027] [Reference Citation Analysis]
4 Johnston DGW, Kirby B, Tobin DJ. Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction? Exp Dermatol 2021;30:1554-68. [PMID: 34418166 DOI: 10.1111/exd.14451] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Anduquia-Garay F, Rodríguez-Gutiérrez MM, Poveda-Castillo IT, Valdes-Moreno PL, Agudelo-Rios DA, Benavides-Moreno JS, Lozada-Martínez ID, Bolaño-Romero MP, Borraez-Segura B, Rahman S. Hidradenitis suppurativa: Basic considerations for its approach: A narrative review. Ann Med Surg (Lond) 2021;68:102679. [PMID: 34401142 DOI: 10.1016/j.amsu.2021.102679] [Reference Citation Analysis]
6 Zouboulis CC, Benhadou F, Byrd AS, Chandran NS, Giamarellos‐bourboulis EJ, Fabbrocini G, Frew JW, Fujita H, González‐lópez MA, Guillem P, Gulliver WPF, Hamzavi I, Hayran Y, Hórvath B, Hüe S, Hunger RE, Ingram JR, Jemec GB, Ju Q, Kimball AB, Kirby JS, Konstantinou MP, Lowes MA, Macleod AS, Martorell A, Marzano AV, Matusiak Ł, Nassif A, Nikiphorou E, Nikolakis G, Nogueira da Costa A, Okun MM, Orenstein LA, Pascual JC, Paus R, Perin B, Prens EP, Röhn TA, Szegedi A, Szepietowski JC, Tzellos T, Wang B, van der Zee HH. What causes hidradenitis suppurativa ?—15 years after. Exp Dermatol 2020;29:1154-70. [DOI: 10.1111/exd.14214] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
7 Nikolakis G, von Stebut E. [Topical and novel device-based therapies for mild hidradenitis suppurativa]. Hautarzt 2021;72:676-85. [PMID: 34223936 DOI: 10.1007/s00105-021-04849-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Krajewski PK, Matusiak Ł, von Stebut E, Schultheis M, Kirschner U, Nikolakis G, Szepietowski JC. Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients. Life (Basel) 2021;11:34. [PMID: 33429896 DOI: 10.3390/life11010034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Navrazhina K, Frew JW, Gilleaudeau P, Sullivan-Whalen M, Garcet S, Krueger JG. Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa. J Allergy Clin Immunol 2021;147:2213-24. [PMID: 33548397 DOI: 10.1016/j.jaci.2020.12.651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
10 Wolk K, Brembach T, Šimaitė D, Bartnik E, Cucinotta S, Pokrywka A, Irmer M, Triebus J, Witte‐händel E, Salinas G, Leeuw T, Volk H, Ghoreschi K, Sabat R. Activity and components of the granulocyte colony‐stimulating factor pathway in hidradenitis suppurativa*. Br J Dermatol 2021;185:164-76. [DOI: 10.1111/bjd.19795] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
11 Del Duca E, Morelli P, Bennardo L, Di Raimondo C, Nisticò SP. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa. Int J Mol Sci 2020;21:E8436. [PMID: 33182701 DOI: 10.3390/ijms21228436] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
12 Gupta AK, Shear NH, Piguet V, Bamimore MA. Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic review and network meta-analyses of randomized trials. J Dermatolog Treat 2021;:1-32. [PMID: 33961535 DOI: 10.1080/09546634.2021.1927949] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Chaffin AE, Buckley M. Extracellular matrix graft for the surgical management of Hurley stage III hidradenitis suppurativa: a pilot case series. J Wound Care 2020;29:624-30. [DOI: 10.12968/jowc.2020.29.11.624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gáspár K, Hunor Gergely L, Jenei B, Wikonkál N, Kinyó Á, Szegedi A, Remenyik É, Kiss N, Jin X, Sárdy M, Beretzky Z, Péntek M, Gulácsi L, Bánvölgyi A, Brodszky V, Rencz F. Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study. Expert Review of Pharmacoeconomics & Outcomes Research. [DOI: 10.1080/14737167.2021.1895753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells 2021;10:2094. [PMID: 34440863 DOI: 10.3390/cells10082094] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Schneider-Burrus S, Tsaousi A, Barbus S, Huss-Marp J, Witte K, Wolk K, Fritz B, Sabat R. Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients. Front Med (Lausanne) 2021;8:676241. [PMID: 33987196 DOI: 10.3389/fmed.2021.676241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Willems D, Charokopou M, Evers SMAA, Hiligsmann M. Early health economic modelling for a treatment candidate in hidradenitis suppurativa. J Med Econ 2020;23:1516-24. [PMID: 33084453 DOI: 10.1080/13696998.2020.1840181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Xiao XM, Yang WZ, Lin LH, Li CR. Two novel nicastrin mutations in Chinese families with acne inversa. J Dermatol 2020;47:e449-51. [PMID: 32940366 DOI: 10.1111/1346-8138.15575] [Reference Citation Analysis]
19 Bató A, Brodszky V, Gergely LH, Gáspár K, Wikonkál N, Kinyó Á, Szabó Á, Beretzky Z, Szegedi A, Remenyik É, Kiss N, Sárdy M, Rencz F. The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa. Qual Life Res 2021;30:1477-90. [PMID: 33534032 DOI: 10.1007/s11136-020-02732-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Teng Y, Tao X, Lu W, Huang Y, Xu D, Li M, Fan Y. Identification of Hidradenitis Suppurativa-Related mRNA Expression Patterns Through Analysis of Gene Expression Omnibus. Dose Response 2020;18:1559325820942646. [PMID: 32782449 DOI: 10.1177/1559325820942646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Aarts P, Dudink K, Vossen ARJV, van Straalen KR, Ardon CB, Prens EP, van der Zee HH. Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa. Drugs 2021;81:1397-410. [PMID: 34283386 DOI: 10.1007/s40265-021-01566-2] [Reference Citation Analysis]
22 Mariottoni P, Jiang SW, Prestwood CA, Jain V, Suwanpradid J, Whitley MJ, Coates M, Brown DA, Erdmann D, Corcoran DL, Gregory SG, Jaleel T, Zhang JY, Harris-Tryon TA, MacLeod AS. Single-Cell RNA Sequencing Reveals Cellular and Transcriptional Changes Associated With M1 Macrophage Polarization in Hidradenitis Suppurativa. Front Med (Lausanne) 2021;8:665873. [PMID: 34504848 DOI: 10.3389/fmed.2021.665873] [Reference Citation Analysis]
23 Gudjonsson JE, Tsoi LC, Ma F, Billi AC, van Straalen KR, Vossen ARJV, van der Zee HH, Harms PW, Wasikowski R, Yee CM, Rizvi SM, Xing X, Xing E, Plazyo O, Zeng C, Patrick MT, Lowe MM, Burney RE, Kozlow JH, Cherry-Bukowiec JR, Jiang Y, Kirma J, Weidinger S, Cushing KC, Rosenblum MD, Berthier C, MacLeod AS, Voorhees JJ, Wen F, Kahlenberg JM, Maverakis E, Modlin RL, Prens EP. Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis. JCI Insight 2020;5:139930. [PMID: 32853177 DOI: 10.1172/jci.insight.139930] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
24 Zhang H, Zhang D, Tang K, Sun Q. The Relationship Between Alzheimer's Disease and Skin Diseases: A Review. Clin Cosmet Investig Dermatol 2021;14:1551-60. [PMID: 34729018 DOI: 10.2147/CCID.S322530] [Reference Citation Analysis]
25 Lindsø Andersen P, Kjaersgaard Andersen R, Jemec GBE, Ullum H, Erikstrup C, Nielsen KR, Bruun MT, Hjalgrim H, Sørensen E, Burgdorf KS, Dinh KM, Banasik K, Hansen T, Saunte DM, Pedersen OB. Superficial fungal infections and patients with hidradenitis suppurativa: a study under the Danish Blood Donor Study. Clin Exp Dermatol 2021;46:571-3. [PMID: 33006774 DOI: 10.1111/ced.14468] [Reference Citation Analysis]
26 Ghoreschi K, Balato A, Enerbäck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 2021;397:754-66. [PMID: 33515492 DOI: 10.1016/S0140-6736(21)00184-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
27 Frew JW, Marzano AV, Wolk K, Join-lambert O, Alavi A, Lowes MA, Piguet V. A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance. Journal of Investigative Dermatology 2021;141:316-324.e2. [DOI: 10.1016/j.jid.2020.06.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
28 Schneider‐burrus S, Lux G, Linde K, Barbus S, Huss‐marp J, Tsaousi A, Wasem J, Wolff B, Sabat R. Hidradenitis suppurativa – prevalence analyses of German statutory health insurance data. J Eur Acad Dermatol Venereol 2021;35. [DOI: 10.1111/jdv.16783] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
29 González‐lópez MA, Ocejo‐viñals JG, Mata C, Vilanova I, Guiral S, Portilla V, Blanco R, Hernández JL. Association of retinol binding protein4 (RBP4) and ghrelin plasma levels with insulin resistance and disease severity in non‐diabetic patients with hidradenitis suppurativa. Exp Dermatol 2020;29:828-32. [DOI: 10.1111/exd.14132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Minakawa S, Matsuzaki Y, Rokunohe D, Kumagai N, Kurose A, Kushibiki M, Kayaba H, Sawamura D. Hidradenitis suppurativa with perifolliculitis capitis abscedens et suffodiens successfully treated with a human anti-tumour necrosis factor monoclonal antibody. Clin Exp Dermatol 2021. [PMID: 34096639 DOI: 10.1111/ced.14789] [Reference Citation Analysis]
31 Wolk K, Join-Lambert O, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa. Br J Dermatol 2020;183:999-1010. [PMID: 33048349 DOI: 10.1111/bjd.19556] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
32 Zimmer S, Basien K, von Stebut E. [Impact of LAight therapy on hidradenitis suppurativa care]. Hautarzt 2021;72:586-94. [PMID: 34125251 DOI: 10.1007/s00105-021-04843-z] [Reference Citation Analysis]
33 Saraç Öztürk G, Ergun T, Peker Eyüboğlu İ, Akkiprik M. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa. Cytokine 2021;144:155585. [PMID: 34034145 DOI: 10.1016/j.cyto.2021.155585] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Frew JW, Lowes MA, Goldfarb N, Butt M, Piguet V, O'Brien E, Ingram J, Jemec GBE, Tan J, Zouboulis C, Alavi A, Kirby JS. Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary. JAMA Dermatol 2021;157:449-55. [PMID: 33688910 DOI: 10.1001/jamadermatol.2020.5467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 van Straalen KR, Prens EP, Willemsen G, Boomsma DI, van der Zee HH. Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-sectional Dutch Twin Cohort. JAMA Dermatol 2020;156:1359-62. [PMID: 33052394 DOI: 10.1001/jamadermatol.2020.3630] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
36 Wark KJL, Cains GD. The Microbiome in Hidradenitis Suppurativa: A Review. Dermatol Ther (Heidelb) 2021;11:39-52. [PMID: 33244661 DOI: 10.1007/s13555-020-00465-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
37 Cao Y, Harvey BP, Hong F, Ruzek M, Wang J, Murphy ER, Kaymakcalan Z. Adalimumab Induces a Wound Healing Profile in Patients with Hidradenitis Suppurativa by Regulating Macrophage Differentiation and Matrix Metalloproteinase Expression. J Invest Dermatol 2021:S0022-202X(21)01217-3. [PMID: 33965402 DOI: 10.1016/j.jid.2021.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Rumberger BE, Boarder EL, Owens SL, Howell MD. Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis. Inflamm Res 2020;69:967-73. [DOI: 10.1007/s00011-020-01381-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
39 Navrazhina K, Garcet S, Gonzalez J, Grand D, Frew JW, Krueger JG. In-Depth Analysis of the Hidradenitis Suppurativa Serum Proteome Identifies Distinct Inflammatory Subtypes. J Invest Dermatol 2021;141:2197-207. [PMID: 33766512 DOI: 10.1016/j.jid.2021.02.742] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
40 Kokolakis G, Wolk K, Schneider-Burrus S, Kalus S, Barbus S, Gomis-Kleindienst S, Sabat R. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System. Dermatology 2020;236:421-30. [PMID: 32610312 DOI: 10.1159/000508787] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
41 McCarthy S, Barrett M, Kirthi S, Pellanda P, Vlckova K, Tobin AM, Murphy M, Shanahan F, O'Toole PW. Altered Skin and Gut Microbiome in Hidradenitis Suppurativa. J Invest Dermatol 2021:S0022-202X(21)01657-2. [PMID: 34364884 DOI: 10.1016/j.jid.2021.05.036] [Reference Citation Analysis]
42 Nikolakis G, Kokolakis G, Kaleta K, Wolk K, Hunger R, Sabat R, Zouboulis CC. [Pathogenesis of hidradenitis suppurativa/acne inversa]. Hautarzt 2021;72:658-65. [PMID: 34228138 DOI: 10.1007/s00105-021-04853-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Okeke CAV, Shipman WD, Perry JD, Kerns ML, Okoye GA, Byrd AS. Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas. J Dermatolog Treat 2020;:1-2. [PMID: 32643464 DOI: 10.1080/09546634.2020.1781042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Derruau S, Gobinet C, Untereiner V, Sockalingum GD, Nassif A, Viguier M, Piot O, Lorimier S. New insights into hidradenitis suppurativa diagnosis via salivary infrared biosignatures: A pilot study. J Biophotonics 2021;14:e202000327. [PMID: 33231348 DOI: 10.1002/jbio.202000327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Lipa K, Zając N, Owczarek W, Ciechanowicz P, Szymaǹska E, Walecka I. Does smoking affect your skin? Postepy Dermatol Alergol 2021;38:371-6. [PMID: 34377115 DOI: 10.5114/ada.2021.103000] [Reference Citation Analysis]
46 Komatsu-Fujii T, Murata T, Adachi E, Kaku Y, Wada T, Nakagawa N, Kosugi S, Uehara T, Kosaki K, Kataoka T, Egawa G, Dainichi T, Kabashima K. Sterile abscesses possibly stem from acantholytic folliculitis in comedonal Darier disease: a case report. Br J Dermatol 2021;185:667-9. [PMID: 33914923 DOI: 10.1111/bjd.20418] [Reference Citation Analysis]
47 Moliterni E, Miraglia E, Iacovino C, Bianchini D, Giustini S. Lichen sclerosus and hidradenitis suppurativa: Two case reports of a new possible association. Australas J Dermatol 2021;62:e92-4. [PMID: 32815154 DOI: 10.1111/ajd.13422] [Reference Citation Analysis]
48 Watkins RR, David MZ. Approach to the Patient with a Skin and Soft Tissue Infection. Infect Dis Clin North Am 2021;35:1-48. [PMID: 33494872 DOI: 10.1016/j.idc.2020.10.011] [Reference Citation Analysis]
49 Howells L, Lancaster N, McPhee M, Bundy C, Ingram JR, Leighton P, Henaghan-Sykes K, Thomas KS. Thematic synthesis of the experiences of people with hidradenitis suppurativa: a systematic review. Br J Dermatol 2021. [PMID: 34050935 DOI: 10.1111/bjd.20523] [Reference Citation Analysis]
50 Mayeur N, Groyer S, Vimeux S, Roustan J. Severe Respiratory and Hemodynamic Failures following Successful Spontaneous Pneumothorax Drainage. Case Rep Emerg Med 2021;2021:6677656. [PMID: 34055425 DOI: 10.1155/2021/6677656] [Reference Citation Analysis]